Scholars@Duke

• Expertise
• 

  Subject Headings

  • Allergy and Immunology
  • Immunological adjuvants
  • Vaccines
• Research
• 

  Selected Grants

  • Vaccine Adjuvant Discovery Program awarded by University of Montana 2019 - 2021
  • Design and Engineering of VesiVax HIV Immunogen Formulations awarded by Molecular Express, Inc. 2020 - 2021
  • Evaluation of Conjugated VesiVax Formulations for HIV Vaccines awarded by Molecular Express, Inc. 2020 - 2021
  • Evaluation of VesiVax Adjuvant Formulations for HIV Vaccines awarded by Molecular Express, Inc. 2019 - 2021
  • Adjuvant Discovery Program (Option #3) awarded by National Institutes of Health 2014 - 2020
  • Adjuvant Discovery Program (Option #2) awarded by National Institutes of Health 2014 - 2019
  • Development of a Peanut Allergy Immunotherapy awarded by Molecular Express, Inc. 2017 - 2019
  • Delivery of Self-Replicating HIV Vaccines Using In Vitro Reconstituted Virus-Like Particles awarded by Molecular Express, Inc. 2018
  • Adjuvant Discovery Program (Option #1) awarded by National Institutes of Health 2014 - 2017
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Johnson-Weaver, Brandi T., Susan McRitchie, Kelly A. Mercier, Wimal Pathmasiri, Susan J. Sumner, Cliburn Chan, Dori Germolec, Michael Kulis, A Wesley Burks, and Herman F. Staats. “Effect of endotoxin and alum adjuvant vaccine on peanut allergy.” J Allergy Clin Immunol 141, no. 2 (February 2018): 791-794.e8. https://doi.org/10.1016/j.jaci.2017.07.043.
       Full Text  Link to Item
    • Roggelin, Louise, Christof D. Vinnemeier, Johanna Fischer-Herr, Brandi T. Johnson-Weaver, Thierry Rolling, Gerd D. Burchard, Herman F. Staats, and Jakob P. Cramer. “Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.” Vaccine 33, no. 33 (August 7, 2015): 4141–45. https://doi.org/10.1016/j.vaccine.2015.05.080.
       Full Text  Link to Item
    • Gwinn, William M., Brandi T. Johnson, Shaun M. Kirwan, Ashley E. Sobel, Soman N. Abraham, Michael D. Gunn, and Herman F. Staats. “A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.” Vaccine 31, no. 11 (March 1, 2013): 1480–89. https://doi.org/10.1016/j.vaccine.2013.01.012.
       Full Text  Link to Item
    • Thompson, Afton L., Brandi T. Johnson, Gregory D. Sempowski, Michael D. Gunn, Baidong Hou, Anthony L. DeFranco, and Herman F. Staats. “Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.” J Immunol 188, no. 6 (March 15, 2012): 2834–46. https://doi.org/10.4049/jimmunol.1100254.
       Full Text  Link to Item

  • Book Sections

    • Choi, H. W., B. Johnson-Weaver, H. F. Staats, and S. N. Abraham. “Mast cells for the control of mucosal immunity.” In Mucosal Vaccines: Innovation for Preventing Infectious Diseases, 213–28, 2019. https://doi.org/10.1016/B978-0-12-811924-2.00013-4.
       Full Text
    • Johnson-Weaver, B. T., S. N. Abraham, and H. F. Staats. “Innate immunity-based mucosal modulators and adjuvants.” In Mucosal Vaccines: Innovation for Preventing Infectious Diseases, 167–83, 2019. https://doi.org/10.1016/B978-0-12-811924-2.00010-9.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.